Trends in HIV and HCV Risk Behaviors and Prevalent Infection Among People Who Inject Drugs in New York City, 2005-2012.

J Acquir Immune Defic Syndr

*HIV Epidemiology and Field Services Program, New York City Department of Health and Mental Hygiene, New York City, NY; †Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, NY; ‡Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA; §Rory Myers College of Nursing, New York University, New York City, NY; ‖St. Ann's Corner of Harm Reduction, New York City, NY; ¶National Development and Research Institutes, New York City, NY; and #Center for HIV/AIDS Education Studies & Training (CHEST), City University of New York-Hunter College, New York City, NY.

Published: July 2017

AI Article Synopsis

  • The study analyzed changes in HIV and hepatitis C virus (HCV) risk behaviors and infection rates among people who inject drugs (PWID) in New York City from 2005 to 2012, using data from the National HIV Behavioral Surveillance study.
  • Results showed significant trends: a decrease in unsafe syringe sources and a rise in syringes obtained from safer outlets, while condomless sex increased; HIV prevalence dropped but HCV remained high among participants.
  • The findings highlight the need for ongoing monitoring of risk behaviors and infections in PWID, as while HIV rates are declining, HCV infection rates and risky behaviors persist.

Article Abstract

Background: We assess trends in HIV and hepatitis C virus (HCV) risk behaviors and prevalent infection among people who inject drugs (PWID) in New York City (NYC).

Methods: PWID in NYC were sampled using respondent-driven sampling in 2005, 2009, and 2012 (serial cross sections) for the Centers for Disease Control and Prevention-sponsored National HIV Behavioral Surveillance study. Participants were interviewed about their current (≤12 months) risk behaviors and tested for HIV and HCV. The crude and adjusted risk ratio (RR) and 95% confidence interval (95% CI) for linear time trends were estimated using generalized estimating equations regression with a modified Poisson model.

Results: The sample comprised 500, 514, and 525 participants in 2005, 2009, and 2012, respectively. Significant (P < 0.05) linear trends in risk behaviors included a decline in unsafe syringe sources (60.8%, 31.3%, 46.7%; RR = 0.86, 95% CI: 0.81 to 0.92), an increase in all syringes from syringe exchanges or pharmacies (35.4%, 67.5%, 50.3%; RR = 1.15, 95% CI: 1.09 to 1.22), and an increase in condomless vaginal or anal sex (53.6%, 71.2%, 70.3%; RR = 1.14, 95% CI: 1.09 to 1.19). Receptive syringe sharing (21.4%, 27.0%, 25.1%), sharing drug preparation equipment (45.4%, 43.4%, 46.7%), and having ≥2 sex partners (51.2%, 44.0%, 50.7%) were stable. Although HIV seroprevalence declined (18.1%, 12.5%, 12.2%), HCV seroprevalence was high (68.2%, 75.8%, 67.1%). In multivariate analysis, adjusting for sample characteristics significantly associated with time, linear time trends remained significant, and the decline in HIV seroprevalence gained significance (adjusted RR = 0.76, 95% CI: 0.64 to 0.91, P = 0.003).

Conclusions: This trend analysis suggests declining HIV prevalence among NYC PWID. However, HCV seroprevalence was high and risk behaviors were considerable. Longitudinal surveillance of HIV and HCV risk behaviors and infections is needed to monitor trends and for ongoing data-informed prevention among PWID.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284853PMC
http://dx.doi.org/10.1097/QAI.0000000000001407DOI Listing

Publication Analysis

Top Keywords

risk behaviors
24
hiv hcv
12
hcv risk
12
trends hiv
8
behaviors prevalent
8
prevalent infection
8
infection people
8
people inject
8
inject drugs
8
york city
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!